“…1,2 These therapies include topical agents (corticosteroids, tar, calcipotriol, dithranol, fluorouracil, and calcineurin inhibitors); phototherapy (psoralen ultraviolet A (PUVA)/ultraviolet B (UVB)); and systemic medications (oral corticosteroids, methotrexate, cyclosporine, retinoids, tetracyclines, colchicine, dapsone, and various biologics). 1,3 Our patient failed conventional plaque psoriasis monotherapy, but the initiation of adalimumab, in addition to alitretinoin and clobetasol propionate, provided disease control without side effects other than xerophthalmia.…”